loader
Please Wait
Applying Filters...
menu
    • menu

    Company Digital Content of Strides Pharma Science

    News
    Strides gets USFDA nod for Theophylline extended-release tablets

    07 Sep 2024

    // ECONOMICTIMES

    Strides Alathur receives EIR from USFDA for its Chennai facility

    19 Aug 2024

    // PRESS RELEASE

    Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr

    01 Aug 2024

    // INDIANPHARMAPOST

    Data Compilation
    #PharmaFlow

    Strides Pharma Science

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Booth #5C33

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-34447.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-3803.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Manufacturing Sites and R&D Center

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-28236.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2021

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-60913.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Strides gets USFDA nod for Theophylline extended-release tablets
    Strides gets USFDA nod for Theophylline extended-release tablets

    07 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-gets-usfda-nod-for-theophylline-extended-release-tablets/articleshow/113115295.cms

    ECONOMICTIMES
    07 Sep 2024
    Share Share
    Strides Alathur receives EIR from USFDA for its Chennai facility
    Strides Alathur receives EIR from USFDA for its Chennai facility

    19 Aug 2024

    // PRESS RELEASE

    https://www.strides.com/pdf/pressrelease/2024/StridesSEIntimation_19_Aug_24.pdf

    PRESS RELEASE
    19 Aug 2024
    Share Share
    Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr
    Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr

    01 Aug 2024

    // INDIANPHARMAPOST

    https://strides.com/pdf/pressrelease/2024/SEIntimationNewspaperAdv_30_Jul_24.pdf

    INDIANPHARMAPOST
    01 Aug 2024
    Share Share
    Strides Pharma Updates On Scheme With Steriscience & Onesource Under Companies
    Strides Pharma Updates On Scheme With Steriscience & Onesource Under Companies

    30 Jul 2024

    // PRESS RELEASE

    https://www.strides.com/pdf/pressrelease/2024/SEIntimation30_Jul_24.pdf

    PRESS RELEASE
    30 Jul 2024
    Share Share
    Newspaper-Unaudited Financial Results for the quarter ended June 30, 2024
    Newspaper-Unaudited Financial Results for the quarter ended June 30, 2024

    30 Jul 2024

    // PRESS RELEASE

    https://www.strides.com/pdf/pressrelease/2024/SEIntimationNewspaperAdv_30_Jul_24.pdf

    PRESS RELEASE
    30 Jul 2024
    Share Share
    Incorporation of Step-down Wholly Owned Subsidiary in New Zealand
    Incorporation of Step-down Wholly Owned Subsidiary in New Zealand

    27 Jul 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/StridesSEIntimationNZIncorp_27_Jul_24.pdf

    PRESS RELEASE
    27 Jul 2024
    Share Share